The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Gilead Sciences Inc

Nasdaq: GILD
Last

(U.S.) $70.50

Today's change+0.56 +0.80%
Updated February 27 4:00 PM EST. Delayed by at least 15 minutes.
 

Gilead Sciences Inc

Nasdaq: GILD
Last

(U.S.) $70.50

Today's change+0.56 +0.80%
Updated February 27 4:00 PM EST. Delayed by at least 15 minutes.

Gilead Sciences Inc crosses above 20-day moving average

Gilead Sciences Inc closed up Monday by (U.S.)$0.56 or 0.80% to (U.S.)$70.50 and crossing above its 20-day moving average. Over the last five days, shares have gained 0.93%, but are currently unchanged over the last year to date. Shares have underperformed the S&P 500 by 41.62% during the last year.

Key company metrics

  • Open(U.S.) $69.82
  • Previous close(U.S.) $69.94
  • High(U.S.) $70.54
  • Low(U.S.) $69.80
  • Bid / Ask(U.S.) $70.38 / (U.S.) $70.49
  • YTD % change-1.55%
  • Volume6,354,099
  • Average volume (10-day)12,205,031
  • Average volume (1-month)12,222,281
  • Average volume (3-month)10,514,029
  • 52-week range(U.S.) $65.38 to (U.S.) $103.10
  • Beta1.15
  • Trailing P/E7.10×
  • P/E 1 year forward8.17×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend(U.S.) $2.08
  • Dividend yield2.95%
  • Trailing EPS(U.S.) $9.94
Updated February 27 4:00 PM EST. Delayed by at least 15 minutes.
S&P TSX0.45%Sector:HealthcareIndustry:Biotechnology
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2016Q3/2016Q2/2016Q1/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016
Revenue7,3207,5007,7767,794
Total other revenue--------
Total revenue7,3207,5007,7767,794
Gross profit6,2456,3716,9126,601
Total cost of revenue1,0751,1298641,193
Total operating expense3,2753,1013,2383,143
Selling / general / administrative992831890685
Research & development1,2081,1411,4841,265
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income4,0454,3994,5384,651
Interest income (expense), net non-operating-265-242-227-230
Gain (loss) on sale of assets--------
Other--------
Income before tax3,9204,2764,3994,502
Income after tax3,0993,3253,4973,567
Income tax, total821951902935
Net income3,1083,3303,4973,566
Total adjustments to net income--------
Net income before extra. items3,1083,3303,4973,566
Minority interest950-1
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items3,1083,3303,4973,566
Inc. avail. to common incl. extra. items3,1083,3303,4973,566
Diluted net income3,1083,3303,4973,566
Dilution adjustment--000
Diluted weighted average shares1,3271,3391,3551,412
Diluted EPS excluding extraordinary itemsvalue per share2.342.492.582.53
Dividends per sharevalue per share0.470.470.470.43
Diluted normalized EPSvalue per share2.342.492.582.53